| 書目名稱 | Pharmacological Interventions for Osteoporosis |
| 編輯 | Andy H. Choi,Sian Yik Lim |
| 視頻video | http://file.papertrans.cn/746/745601/745601.mp4 |
| 概述 | Presents the basic properties of pharmaceutical agents in the treatment of osteoporosis.Compares pharmaceutical agents for the intervention of osteoporosis.Highlights the awareness of long-term treatm |
| 叢書名稱 | Tissue Repair and Reconstruction |
| 圖書封面 |  |
| 描述 | This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.. |
| 出版日期 | Book 2023 |
| 關鍵詞 | Osteoporosis; Bone Resorption; Fracture Risk; Monoclonal Antibodies; Bone Remodeling; Bisphosphonates; Den |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-981-99-5826-9 |
| isbn_softcover | 978-981-99-5825-2 |
| isbn_ebook | 978-981-99-5826-9Series ISSN 2731-9180 Series E-ISSN 2731-9199 |
| issn_series | 2731-9180 |
| copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 17:25
發(fā)表于 2025-3-21 19:19:48
